SUS's share of industry expenditures, which include Federal, State and Municipal governments, has grown from 41.7% in 2006, to 46% in 2013.

Noida, UP -- (SBWire) -- 01/30/2015 --According to a new research report by RNCOS entitled, "Brazil Pharmaceutical Market Outlook 2018", Brazil is among the few countries in the world to have a universal and free public health-care system. The taxes paid by Brazilians cover all kinds of services and treatments offered by the National Health System (System UNICCO de Saudi, SUS), without charging any additional amounts to the user. SUS's share of industry expenditures, which include Federal, State and Municipal governments, has grown from 41.7% in 2006, to the current level of 46%. In addition, starting in 2013, the country planned that at least 12% of State and 15% of municipal resources would be available for investment in healthcare.

The SUS system has been showing significant involvement in the low income group by providing free medicines. This factor will have a positive impact on public share, increasing it to 50% in near future. Another form of financing and expanding public health services already operating in Brazil is the implementation of Public Private Partnerships (PPPs), which has significantly grown recently. These contracts are currently concentrated in hospital construction, and operation and outpatient service facilities.

The report provides an in-depth research and rational analysis of the current status and future prospect of the Brazilian Pharmaceutical industry. The study presents a transparent picture about different pharma segments such as Generics, OTC and Prescription Drugs including the factors affecting their growth. The research further covers Pharmaceutical Production, Therapeutic Segments, Growth Drivers and Challenges as well as Mergers and Acquisitions.

The report also covers detailed information about active market players in the Brazil pharmaceutical industry, including domestic and foreign players to enable the clients understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the Brazilian Pharmaceutical market, providing an in-depth research and prudent analysis of the key segments.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM726.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.